Label: LBEL EFFET PARFAIT- titanium dioxide, oxybenzone, and octinoxate powder

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 25, 2012

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • ACTIVE INGREDIENT

    Active IngredientPurpose
    Titanium Dioxide 4.425%Sunscreen
    Oxybenzone 3.0 %Sunscreen
    Octinoxate 4.0%,Sunscreen
  • Uses

    • Helps prevent sunburn
    • Higher SPF gives more sunburn protection
    • Provides moderate protection against sunburn
  • Warnings

    For external use only

    When using this product

    • Keep out of eyes. Rinse with water to remove

    Stop use and ask a doctor if

    • Rash or irritation develops and lasts

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • Apply generously and evently before sun exposure and as needed
  • Inactive ingredients

    Talc, Mica, Boron Nitride, Alumina, Benzimidazole Diamond Amidoethyl Urea Carbamoyl Propyl Polymethylsilsesquioxane, Kaolin, Glyceryl Caprylate, Isononyl Isononanoate, Glycerin, Lycopodium Clavatum Exine, Hydrogen Dimethicone, Lauroyl Lysine, Fragrance, Ceramide 3, Methylparaben, Propylparaben, Imperata Cylindrica Root Extract. May Contain: CI 77491, CI 77492, CI 77499 (Iron Oxides), CI 77891 (Titanium Dioxide).

  • SPL UNCLASSIFIED SECTION

    PUERTO RICO: Dist. by Ventura Corporation, Ltd., San Juan, Puerto Rico 00926. Made in Colombia.

  • PRINCIPAL DISPLAY PANEL - 10 g Compact Carton

    EFFET PARFAIT

    moisturizing compact powder SPF 15

    10 g e (.35 oz.)

    L'BEL

    Principal Display Panel - 10 g Compact Carton
  • INGREDIENTS AND APPEARANCE
    LBEL   EFFET PARFAIT
    titanium dioxide, oxybenzone, and octinoxate powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-148
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE0.04425 g  in 1 g
    OXYBENZONE (UNII: 95OOS7VE0Y) (OXYBENZONE - UNII:95OOS7VE0Y) OXYBENZONE0.03 g  in 1 g
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.04 g  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    TALC (UNII: 7SEV7J4R1U)  
    MICA (UNII: V8A1AW0880)  
    BORON NITRIDE (UNII: 2U4T60A6YD)  
    ALUMINUM OXIDE (UNII: LMI26O6933)  
    KAOLIN (UNII: 24H4NWX5CO)  
    GLYCERYL CAPRYLATE (UNII: TM2TZD4G4A)  
    ISONONYL ISONONANOATE (UNII: S4V5BS6GCX)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    LAUROYL LYSINE (UNII: 113171Q70B)  
    CERAMIDE 3 (UNII: 4370DF050B)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    IMPERATA CYLINDRICA ROOT (UNII: VYT2JA85NH)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:13537-148-021 in 1 BOX
    1NDC:13537-148-0110 g in 1 CASE
    2NDC:13537-148-041 in 1 BOX
    2NDC:13537-148-037.8 g in 1 CASE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH NOT FINALpart35201/24/2012
    Labeler - Ventura Corporation Ltd (602751344)
    Establishment
    NameAddressID/FEIBusiness Operations
    Bel Star S.A. (Colombia)880160197MANUFACTURE(13537-148)